(Q35868449)

10 August 2017

The Immunosuppressive Activity of Amniotic Membrane Mesenchymal Stem Cells on T Lymphocytes (English)

1 reference

10 August 2017

mesenchymal stem cell

1 reference

Fatemeh Alikarami

1

1 reference

10 August 2017

Fatemeh Yari

2

1 reference

10 August 2017

Naser Amirizadeh

3

1 reference

10 August 2017

Mahin Nikougoftar

4

1 reference

10 August 2017

Mohammad Ali Jalili

5

1 reference

10 August 2017

1 July 2015

1 reference

Avicenna Journal of Medical Biotechnology

10 August 2017

1 reference

10 August 2017

7

1 reference

10 August 2017

3

1 reference

10 August 2017

90-96

1 reference

Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Different populations and sources of human mesenchymal stem cells (MSC): A comparison of adult and neonatal tissue-derived MSC.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells and autoimmune diseases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Review: Preclinical studies on placenta-derived cells and amniotic membrane: an update

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells for clinical application

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells suppress B-cell terminal differentiation.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Immunoregulatory function of mesenchymal stem cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Human mesenchymal stem cells modulate allogeneic immune cell responses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Isolation and characterization of mesenchymal stem cells from the amniotic membrane.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Homing of in vitro expanded Stro-1- or Stro-1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Mesenchymal stem cells and hematopoietic stem cell transplantation

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4508338

Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells

24 September 2018

1 reference

12 December 2020

T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression

1 reference

12 December 2020

Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex

1 reference

12 December 2020

[Effect of human bone marrow mesenchymal stem cells on T lymphocyte killing K562 cells]

1 reference

12 December 2020

Isolation of mesenchymal stromal cells from extraembryonic tissues and their characteristics

1 reference

12 December 2020

T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia

1 reference

12 December 2020

Isolation and Characterization of Mesenchymal Stem Cells from Human Amniotic Membrane

1 reference

12 December 2020

Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells

1 reference

12 December 2020

Identifiers

1 reference

10 August 2017

PubMed publication ID

26306147

1 reference